REQUEST A DEMO
Total
USD $0.00
Search more companies

Biologicals S.R.O. (Czech Republic)

Main Activities: Newspaper, Periodical, Book, and Directory Publishers
Full name: Biologicals S.R.O. Profile Updated: October 21, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English Download a sample report

Biologicals S.R.O. is based in Czech Republic, with the head office in Ricany. It operates in the Newspaper, Periodical, Book, and Directory Publishers sector. The company was established on July 17, 2006. It currently has a total number of 1 - 5 (2023) employees. There was a net sales revenue increase of 20.91% reported in Biologicals S.R.O.’s latest financial highlights for 2024. During that time, Biologicals S.R.O.’s total assets grew by 6.42%. The net profit margin of Biologicals S.R.O. increased by 14.88% in 2024.

Headquarters
Sramkova 315/10
Ricany; Stredocesky; Postal Code: 25101

Contact Details: Purchase the Biologicals S.R.O. report to view the information.

Basic Information
Total Employees:
Purchase the Biologicals S.R.O. report to view the information.
Registered Capital:
Purchase the Biologicals S.R.O. report to view the information.
Financial Auditors:
Purchase the Biologicals S.R.O. report to view the information.
Incorporation Date:
July 17, 2006
Key Executives
Purchase this report to view the information.
Legal Representative
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Biologicals S.R.O. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency CZK. Absolute financial data is included in the purchased report.
Net sales revenue
20.91%
Total operating revenue
20.75%
Operating profit (EBIT)
1053.27%
EBITDA
1214.95%
Net Profit (Loss) for the Period
22233.33%
Total assets
6.42%
Total equity
6.58%
Operating Profit Margin (ROS)
12.34%
Net Profit Margin
14.88%
Return on Equity (ROE)
6.15%
Debt to Equity Ratio
-0.11%
Quick Ratio
4.04%
Cash Ratio
10.19%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?